Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Chung

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained RemissionJeffrey R Curtis, Paul Emery, Elaine Karis, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With ApremilastJerry Bagel, Ahmed S Samad, Bradley S Stolshek, et al.
Rheumatology and Therapy|March 28, 2019
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled TrialStanley Cohen, Ahmed Samad, Elaine Karis, et al.
RMD Open|October 1, 2019
Measurement properties of the minimal disease activity criteria for psoriatic arthritisLaura C Coates, Vibeke Strand, Hilary Wilson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 13, 2019
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III TrialPhilip J Mease, Dafna D Gladman, David H Collier, et al.
RMD Open|March 14, 2018
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)Philip J Mease, Dafna D Gladman, Ahmed S Samad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2018
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus ArthritisLaurence E Cheng, Zahir Amoura, Benjamin Cheah, et al.
Arthritis Research & Therapy|November 30, 2013
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritisDavid A Martin, Melvin Churchill, Luis Flores-Suarez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus ErythematosusVictoria P Werth, David Fiorentino, Barbara A Sullivan, et al.
Rheumatology (Oxford, England)|September 1, 2020
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritisLaura C Coates, Joseph F Merola, Philip J Mease, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained RemissionJeffrey R Curtis, Paul Emery, Elaine Karis, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With ApremilastJerry Bagel, Ahmed S Samad, Bradley S Stolshek, et al.
Rheumatology and Therapy|March 28, 2019
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled TrialStanley Cohen, Ahmed Samad, Elaine Karis, et al.
RMD Open|October 1, 2019
Measurement properties of the minimal disease activity criteria for psoriatic arthritisLaura C Coates, Vibeke Strand, Hilary Wilson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 13, 2019
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III TrialPhilip J Mease, Dafna D Gladman, David H Collier, et al.
RMD Open|March 14, 2018
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)Philip J Mease, Dafna D Gladman, Ahmed S Samad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2018
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus ArthritisLaurence E Cheng, Zahir Amoura, Benjamin Cheah, et al.
Arthritis Research & Therapy|November 30, 2013
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritisDavid A Martin, Melvin Churchill, Luis Flores-Suarez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus ErythematosusVictoria P Werth, David Fiorentino, Barbara A Sullivan, et al.
Rheumatology (Oxford, England)|September 1, 2020
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritisLaura C Coates, Joseph F Merola, Philip J Mease, et al.
Pageof 3